1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68532F7A98C72D73365257F1F00349068
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-developing-high-performance-market-research-structures-reflect-organization-portfolio-maturity?opendocument
18
19opendocument
2018.205.96.39
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Research, Analytics and Forecasting Market Research Structure

Developing High-Performance Market Research Structures That Reflect Organization & Portfolio Maturity

ID: 5392


Features:

13 Info Graphics

7 Data Graphics

90 Metrics

5 Narratives


Pages/Slides: 23


Published: 2015


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Developing High-Performance Market Research Structures That Reflect Organization & Portfolio Maturity”

STUDY OVERVIEW

The Market Research function within biopharmaceutical companies has evolved from a tactically focused role to one that is more strategically focused to help organizations navigate a complex and ever-changing marketplace. This continuing evolution has organizations reviewing the structure of their market research function to balance efficiency and effectiveness across global markets.

As portfolios grow larger and more complex, it is crucial for biopharmaceutical companies to determine the structural approach that works best for enhancing the effectiveness of their market research groups. Best Practices, LLC examined the evolution of market research structures based upon existing benchmark studies conducted between 2007 and 2015 and integrated the analysis into one document. This document also provides an overview of centralized, decentralized, hybrid and globalized market research structures along with case examples.

KEY TOPICS

Key Factors Driving Market Research Structure Changes
Centralized MR Structure – Case Snapshot
Decentralized Structure – Case Snapshot
Hybrid MR Structure – Case Snapshot
Decentralized Regional Approach to EU Market
Hub-and-Spokes Model Approach To EU Regional Market
Marketing Services Approach
Primary Department in which various analytics activities are performed
Marketing Services Location Specialization
Success at Meeting Objectives
Real World Issues & Adaptations

SAMPLE KEY FINDING

Structure Evolution: Portfolio growth and complexity consistently stimulate MR structure evolution. As new products, therapeutic areas and business units appear, structure evolves to reflect TA needs and usually move into more geographic markets.

METHODOLOGY

Analysis reflects multiple benchmark studies conducted between 2007 and 2015 capturing biopharmaceutical industry structure changes across Market Research and Marketing Services organizations.


Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research


Companies Profiled:
Pharma; Biotech; Medical Device Companies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.